Literature DB >> 21354407

Induced conformational changes in the activation of the Pseudomonas aeruginosa type III toxin, ExoU.

Marc A Benson1, Steven M Komas, Katherine M Schmalzer, Monika S Casey, Dara W Frank, Jimmy B Feix.   

Abstract

ExoU is a 74-kDa, water-soluble toxin injected directly into mammalian cells through the type III secretion system of the opportunistic pathogen, Pseudomonas aeruginosa. Previous studies have shown that ExoU is a Ca(2+)-independent phospholipase that requires a eukaryotic protein cofactor. One protein capable of activating ExoU and serving as a required cofactor was identified by biochemical and proteomic methods as superoxide dismutase (SOD1). In these studies, we carried out site-directed spin-labeling electron paramagnetic resonance spectroscopy to examine the effects of SOD1 and substrate liposomes on the structure and dynamics of ExoU. Local conformational changes within the catalytic site were observed in the presence of substrate liposomes, and were enhanced by the addition of SOD1 in a concentration-dependent manner. Conformational changes in the C-terminal domain of ExoU were observed upon addition of cofactor, even in the absence of liposomes. Double electron-electron resonance experiments indicated that ExoU samples multiple conformations in the resting state. In contrast, addition of SOD1 induced ExoU to adopt a single, well-defined conformation. These studies provide, to our knowledge, the first direct evidence for cofactor- and membrane-induced conformational changes in the mechanism of activation of ExoU.
Copyright © 2011 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21354407      PMCID: PMC3043214          DOI: 10.1016/j.bpj.2011.01.056

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  45 in total

Review 1.  A new spin on protein dynamics.

Authors:  Linda Columbus; Wayne L Hubbell
Journal:  Trends Biochem Sci       Date:  2002-06       Impact factor: 13.807

2.  Role of the membrane localization domain of the Pseudomonas aeruginosa effector protein ExoU in cytotoxicity.

Authors:  Jeff L Veesenmeyer; Heather Howell; Andrei S Halavaty; Sebastian Ahrens; Wayne F Anderson; Alan R Hauser
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

3.  Molecular architecture of the KvAP voltage-dependent K+ channel in a lipid bilayer.

Authors:  Luis G Cuello; D Marien Cortes; Eduardo Perozo
Journal:  Science       Date:  2004-10-15       Impact factor: 47.728

4.  Structural studies on transmembrane proteins. 2. Spin labeling of bacteriorhodopsin mutants at unique cysteines.

Authors:  C Altenbach; S L Flitsch; H G Khorana; W L Hubbell
Journal:  Biochemistry       Date:  1989-09-19       Impact factor: 3.162

5.  Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa.

Authors:  Alan R Hauser; Enesha Cobb; Maria Bodi; Dolors Mariscal; Jordi Vallés; Joanne N Engel; Jordi Rello
Journal:  Crit Care Med       Date:  2002-03       Impact factor: 7.598

Review 6.  CFTR mutations and host susceptibility to Pseudomonas aeruginosa lung infection.

Authors:  Gerald B Pier
Journal:  Curr Opin Microbiol       Date:  2002-02       Impact factor: 7.934

7.  In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors.

Authors:  Rebecca M Phillips; David A Six; Edward A Dennis; Partho Ghosh
Journal:  J Biol Chem       Date:  2003-08-12       Impact factor: 5.157

8.  Spectroscopic evidence that osmolytes used in crystallization buffers inhibit a conformation change in a membrane protein.

Authors:  Gail E Fanucci; Jae Y Lee; David S Cafiso
Journal:  Biochemistry       Date:  2003-11-18       Impact factor: 3.162

9.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

Authors:  Hilmar Wisplinghoff; Tammy Bischoff; Sandra M Tallent; Harald Seifert; Richard P Wenzel; Michael B Edmond
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

10.  The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU.

Authors:  Hiromi Sato; Dara W Frank; Cecilia J Hillard; Jimmy B Feix; Ravi R Pankhaniya; Kiyoshi Moriyama; Viviane Finck-Barbançon; Adam Buchaklian; Ming Lei; Roy M Long; Jeanine Wiener-Kronish; Teiji Sawa
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

View more
  12 in total

1.  Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU.

Authors:  David M Anderson; Katherine M Schmalzer; Hiromi Sato; Monika Casey; Scott S Terhune; Arthur L Haas; Jimmy B Feix; Dara W Frank
Journal:  Mol Microbiol       Date:  2011-11-21       Impact factor: 3.501

2.  Identification of the major ubiquitin-binding domain of the Pseudomonas aeruginosa ExoU A2 phospholipase.

Authors:  David M Anderson; Jimmy B Feix; Andrew L Monroe; Francis C Peterson; Brian F Volkman; Arthur L Haas; Dara W Frank
Journal:  J Biol Chem       Date:  2013-08-01       Impact factor: 5.157

3.  Cooperative Substrate-Cofactor Interactions and Membrane Localization of the Bacterial Phospholipase A2 (PLA2) Enzyme, ExoU.

Authors:  Maxx H Tessmer; David M Anderson; Adam Buchaklian; Dara W Frank; Jimmy B Feix
Journal:  J Biol Chem       Date:  2017-01-09       Impact factor: 5.157

4.  Identification of a ubiquitin-binding interface using Rosetta and DEER.

Authors:  Maxx H Tessmer; David M Anderson; Adam M Pickrum; Molly O Riegert; Rocco Moretti; Jens Meiler; Jimmy B Feix; Dara W Frank
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-02       Impact factor: 11.205

5.  Phosphatidylinositol 4,5-Bisphosphate-Dependent Oligomerization of the Pseudomonas aeruginosa Cytotoxin ExoU.

Authors:  Angelica Zhang; Jeffrey L Veesenmeyer; Alan R Hauser
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

6.  Conformational Changes and Membrane Interaction of the Bacterial Phospholipase, ExoU: Characterization by Site-Directed Spin Labeling.

Authors:  Jimmy B Feix; Samantha Kohn; Maxx H Tessmer; David M Anderson; Dara W Frank
Journal:  Cell Biochem Biophys       Date:  2018-07-25       Impact factor: 2.194

7.  Structure of the type III secretion effector protein ExoU in complex with its chaperone SpcU.

Authors:  Andrei S Halavaty; Dominika Borek; Gregory H Tyson; Jeff L Veesenmeyer; Ludmilla Shuvalova; George Minasov; Zbyszek Otwinowski; Alan R Hauser; Wayne F Anderson
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

8.  Structural basis of cytotoxicity mediated by the type III secretion toxin ExoU from Pseudomonas aeruginosa.

Authors:  Claire Gendrin; Carlos Contreras-Martel; Stéphanie Bouillot; Sylvie Elsen; David Lemaire; Dimitrios A Skoufias; Philippe Huber; Ina Attree; Andréa Dessen
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

Review 9.  Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review.

Authors:  Teiji Sawa; Masaru Shimizu; Kiyoshi Moriyama; Jeanine P Wiener-Kronish
Journal:  Crit Care       Date:  2014-12-13       Impact factor: 9.097

10.  Structure and Dynamics of Type III Secretion Effector Protein ExoU As determined by SDSL-EPR Spectroscopy in Conjunction with De Novo Protein Folding.

Authors:  Axel W Fischer; David M Anderson; Maxx H Tessmer; Dara W Frank; Jimmy B Feix; Jens Meiler
Journal:  ACS Omega       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.